KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Accounts Payables: 2013-2024

Historic Accounts Payables for Palvella Therapeutics (PVLA) over the last 11 years, with Sep 2024 value amounting to $801,000.

  • Palvella Therapeutics' Accounts Payables fell 71.56% to $801,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $801,000, marking a year-over-year decrease of 71.56%. This contributed to the annual value of $936,000 for FY2023, which is 77.47% down from last year.
  • According to the latest figures from Q3 2024, Palvella Therapeutics' Accounts Payables is $801,000, which was down 17.34% from $969,000 recorded in Q2 2024.
  • Over the past 5 years, Palvella Therapeutics' Accounts Payables peaked at $19.7 million during Q3 2021, and registered a low of $801,000 during Q3 2024.
  • For the 3-year period, Palvella Therapeutics' Accounts Payables averaged around $4.8 million, with its median value being $3.6 million (2022).
  • As far as peak fluctuations go, Palvella Therapeutics' Accounts Payables soared by 170.65% in 2021, and later tumbled by 87.26% in 2024.
  • Quarterly analysis of 5 years shows Palvella Therapeutics' Accounts Payables stood at $7.7 million in 2020, then grew by 11.36% to $8.6 million in 2021, then tumbled by 51.75% to $4.2 million in 2022, then slumped by 77.47% to $936,000 in 2023, then tumbled by 71.56% to $801,000 in 2024.
  • Its Accounts Payables was $801,000 in Q3 2024, compared to $969,000 in Q2 2024 and $1.5 million in Q1 2024.